We are live on ! Find out more
BCM

Bayesian Capital Management Portfolio holdings

AUM $81.9M
1-Year Est. Return 26.59%
This Fund
S&P 500
This Quarter Est. Return
-1.32%
1 Year Est. Return
+26.59%
3 Year Est. Return
+112.98%
5 Year Est. Return
+129.77%
10 Year Est. Return
+1,146.62%
AUM
$493M
AUM Growth
-$43.7M
Cap. Flow
-$6.65M
Cap. Flow %
-1.35%
Top 10 Hldgs %
14.21%
Holding
1,115
New
370
Increased
135
Reduced
155
Closed
453

Top Sells

Rank Stock Value
1
TFC icon
Truist Financial
TFC
+$6.76M
2
QCOM icon
Qualcomm
QCOM
+$6.11M
3
WBA
Walgreens Boots Alliance
WBA
+$4.04M
4
EOG icon
EOG Resources
EOG
+$4.02M
5
TMUS icon
T-Mobile US
TMUS
+$3.82M

Sector Composition

Rank Sector Weight
1 Technology 24.08%
2 Healthcare 13.66%
3 Consumer Discretionary 12.3%
4 Industrials 9.83%
5 Financials 9.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DNMR
1076
DELISTED
Danimer Scientific, Inc.
DNMR
-325
Closed -$59K
GTHX
1077
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
-23,800
Closed -$118K
AFIB
1078
DELISTED
Acutus Medical Inc
AFIB
-10,672
Closed -$12K
CBD
1079
DELISTED
Companhia Brasileira de Distribuicao
CBD
-30,800
Closed -$95K
SPLK
1080
DELISTED
Splunk Inc
SPLK
-11,000
Closed -$973K
SNCE
1081
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
-1,624
Closed -$65K
MRTX
1082
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
-16,493
Closed -$1.11M
CHS
1083
DELISTED
Chicos FAS, Inc.
CHS
-16,000
Closed -$80K
LTHM
1084
DELISTED
Livent Corporation
LTHM
-39,682
Closed -$900K
VRTV
1085
DELISTED
VERITIV CORPORATION
VRTV
-2,508
Closed -$272K
NEWR
1086
DELISTED
New Relic, Inc.
NEWR
-9,000
Closed -$450K
TWNK
1087
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
-24,700
Closed -$524K
AVID
1088
DELISTED
Avid Technology Inc
AVID
-12,071
Closed -$313K
DEN
1089
DELISTED
Denbury Inc.
DEN
-14,500
Closed -$870K
CANO
1090
DELISTED
Cano Health, Inc.
CANO
-799
Closed -$350K
RAD
1091
DELISTED
Rite Aid Corporation
RAD
-12,947
Closed -$87K
RETA
1092
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
-20,267
Closed -$616K
PRTK
1093
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
-10,700
Closed -$21K
APPH
1094
DELISTED
AppHarvest, Inc. Common Stock
APPH
-23,100
Closed -$81K
MNTV
1095
DELISTED
Momentive Global Inc. Common Stock
MNTV
-25,900
Closed -$228K
SUMO
1096
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
-27,800
Closed -$208K
DCT
1097
DELISTED
Duck Creek Technologies, Inc. Common Stock
DCT
-20,347
Closed -$302K
SFT
1098
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
-7,700
Closed -$52K
RUBY
1099
DELISTED
Rubius Therapeutics, Inc
RUBY
-14,080
Closed -$12K
STOR
1100
DELISTED
STORE Capital Corporation
STOR
-40,926
Closed -$1.07M

Similar funds

Bayesian Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, Bayesian Capital Management held 1,115 positions worth $493M, down 8.1% from $537M the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Bayesian Capital Management's Q3 2022 filing shows 370 new, 135 increased, 155 reduced and 453 closed positions. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 39,700 shares worth $14.2M. The largest sale was Truist Financial, an estimated $6.76M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Bayesian Capital Management's largest Q3 2022 buy was State Street SPDR S&P 500 ETF Trust: 39,700 shares worth $14.2M.
  • Bayesian Capital Management added most to Medtronic in Q3 2022, an estimated $7.24M increase.
  • Bayesian Capital Management's biggest Q3 2022 reduction was Truist Financial, cutting an estimated $6.76M.
  • Bayesian Capital Management fully exited Walgreens Boots Alliance in Q3 2022, selling an estimated $4.04M.
  • Bayesian Capital Management's ten largest holdings make up 14% of its $493M portfolio in Q3 2022.
  • Bayesian Capital Management opened 370 new positions and closed 453 in Q3 2022.
  • Bayesian Capital Management's portfolio value fell 8.1% quarter-over-quarter to $493M.

Based on Bayesian Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.